Probiotic Effects on the Microbe-brain-gut Interaction and Brain Activity During Stress Tasks in Healthy Subjects
1 other identifier
interventional
22
1 country
1
Brief Summary
The aim of this study is to determine if and how the "Probiotic Product" affects functional brain responses in healthy subjects during an emotional- and arithmetic stress task, respectively and in terms of microbe-brain-gut interactions.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jan 2018
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 22, 2018
CompletedFirst Submitted
Initial submission to the registry
June 8, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 16, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
June 16, 2018
CompletedFirst Posted
Study publicly available on registry
August 6, 2018
CompletedAugust 6, 2018
July 1, 2018
5 months
June 8, 2018
July 30, 2018
Conditions
Outcome Measures
Primary Outcomes (1)
Change in brain response to validated emotional challenge task (EAT) during functional brain imaging
Comparing week 4 and 12
Secondary Outcomes (1)
Change in brain response to a cognitive challenge task (MIST) during functional brain imaging
Comparing week 4 and 12
Other Outcomes (15)
Change in physical activity assessed by an actigraphy watch (actiwatch)
Comparing the change in week 0 compared to 4, and 8 compared to 12 (before and in the end of the two intervention periods)
Change in sleep quality assessed by an actigraphy watch (actiwatch)
Comparing the change in week 0 compared to 4, and 8 compared to 12 (before and in the end of the two intervention periods)
Change in daily stress levels assessed by an actigraphy watch (actiwatch)
Comparing the change in week 0 compared to 4, and 8 compared to 12 (before and in the end of the two intervention periods)
- +12 more other outcomes
Study Arms (2)
Placebo
PLACEBO COMPARATORAll study participants will receive the study product and the placebo in a randomized, double-blind crossover fashion. Probiotic and placebo products have similar appearance and taste.
Probiotic
EXPERIMENTALAll study participants will receive the study product and the placebo in a randomized, double-blind crossover fashion. Probiotic and placebo products have similar appearance and taste.
Interventions
The Probiotic Formula is commercially available and contains a combination of 3 probiotic strains in addition to other nutrients. The total daily amount of probiotic strain in the product will be no less than 3 billion colony-forming units (CFU) per 3 g powder sachet.
Eligibility Criteria
You may qualify if:
- Age: Age: 18-65 years, males/females.
- Signed informed consent -
You may not qualify if:
- Concurrent or recent treatment with drugs affecting intestinal function or mood, e.g., antidepressants (\< 12 weeks) or antibiotics (\< 12 weeks).
- Concurrent or recent (\< 4 weeks) use of nutritional supplements or herb products affecting intestinal function or mood (e.g. aloe vera, St. John´s Wort, fibers, prebiotics and probiotics).
- Diagnosis of major psychiatric or somatic disease. 4) Abuse of alcohol or drugs. 5) Recent (\< 4 weeks) intake of proton pump inhibitors, proton pump inhibitors, PPIs (e.g., omeprazole).
- \) Asthma. 7) Cardiovascular diseases. 8) Epilepsy. 9) Renal failure. 10) Cerebral bleeding or history of cerebral bleeding. 11) Allergic to latex. 12) Pregnancy (assessed by urine test) or breastfeeding. 13) Claustrophobia. 14) Smoking or using tobacco including snuff. 15) Inability to maintain exercise routine and dietary pattern during the study.
- \) Consumption of more than 6 cups of coffee/caffeine-containing beverages per day.
- \) Professional athlete. 18) Dominant left-hand. 19) Medical implant (e.g., pacemaker). 20) Aneurysm clips in the head. 21) Shunts in the head. 22) Grenade-splinter or metal-splinter in the body (e.g., eyes). 23) Metal or electrodes in the body (e.g., temp-catheter, aorta stent, cochlea implant).
- \) Comprehensive tooth-implants or prothesis. 25) Operated in the head. 26) Operated in the heart. 27) Swallowed a video-capsule. 28) Non-corrected astigmatism. 29) Regular intake of systemic corticosteroids and anti-inflammatory medication (including NSAIDs) during the last three months.
- \) Visual defect without possibility to use lenses during MRI scanning. 31) Known allergy to milk or soy. 32) Any other reason the investigator feels the subject is not suitable for participation in the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Örebro University, Swedenlead
- Pfizercollaborator
Study Sites (1)
Örebro University, Campus USÖ, Örebro University Hospital
Örebro, 70182, Sweden
Related Publications (1)
Rode J, Edebol Carlman HMT, Konig J, Repsilber D, Hutchinson AN, Thunberg P, Andersson P, Persson J, Kiselev A, Lathrop Stern L, Salomon B, Mohammed AA, Labus JS, Brummer RJ. Probiotic Mixture Containing Lactobacillus helveticus, Bifidobacterium longum and Lactiplantibacillus plantarum Affects Brain Responses Toward an Emotional Task in Healthy Subjects: A Randomized Clinical Trial. Front Nutr. 2022 Apr 29;9:827182. doi: 10.3389/fnut.2022.827182. eCollection 2022.
PMID: 35571902DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Robert Brummer, Prof
Örebro University, Sweden
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- BASIC SCIENCE
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor, MD
Study Record Dates
First Submitted
June 8, 2018
First Posted
August 6, 2018
Study Start
January 22, 2018
Primary Completion
June 16, 2018
Study Completion
June 16, 2018
Last Updated
August 6, 2018
Record last verified: 2018-07
Data Sharing
- IPD Sharing
- Will not share